Safety, Reactogenicity and Immunogenicity of a Venezuelan Equine Encephalitis DNA Vaccine Candidate Administered by Jet Injection
Clinical trial NCT06002503 · UNKNOWN
Trial details
- NCT number
- NCT06002503
- Sponsor
- PharmaJet, Inc.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-10-16
- Primary completion
- 2025-05-31
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.